TGFB1 and hypertrophy: Consistently, Zhao et al. (2017) reported that RIP2 knockout could mitigate AB-induced cardiac hypertrophy, fibrosis, and inflammation via reducing TLR4/MyD88/NF-κB, MAPKs, and TGF-β/Smad signaling.